| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |